Olaratumab Efficacy in Soft-Tissue Sarcoma

Olaratumab Efficacy in Soft-Tissue Sarcoma

Dr. Van Tine Discusses the Development of Olaratumab in SarcomaПодробнее

Dr. Van Tine Discusses the Development of Olaratumab in Sarcoma

FDA Approval of Olaratumab + Doxorubicin for STSПодробнее

FDA Approval of Olaratumab + Doxorubicin for STS

Registration Trials for Olaratumab and Doxorubicin for STSПодробнее

Registration Trials for Olaratumab and Doxorubicin for STS

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue SarcomaПодробнее

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

Olaratumab for STSПодробнее

Olaratumab for STS